Companion Diagnostic Tests in Oncology Market Report

Companion Diagnostic Tests in Oncology Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 01, 2020
  • PAGES：138
  • REPORT CODE：GMM419238
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Companion Diagnostic Tests in Oncology market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.7% during the forecast period.

    This report presents the market size and development trends by detailing the Companion Diagnostic Tests in Oncology market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Companion Diagnostic Tests in Oncology market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Companion Diagnostic Tests in Oncology industry and will help you to build a panoramic view of the industrial development.

    Companion Diagnostic Tests in Oncology Market, By Type:

    • Protein Detection

    • DNA Detection

    Companion Diagnostic Tests in Oncology Market, By Application:

    • Pharmaceutical & Biotechnology Companies

    • Medical Device Companies

    • Research Institutes

    Some of the leading players are as follows:

    • Company 1

    • Company 2

    • Company 3

    • Company 4

    • Company 5

    • Company 6

    • Company 7

    • Company 8

    • Company 9

    • Company 10

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Companion Diagnostic Tests in Oncology Market: Technology Type Analysis

    • 4.1 Companion Diagnostic Tests in Oncology Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Companion Diagnostic Tests in Oncology Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Protein Detection

      • 4.3.2 DNA Detection

    5 Companion Diagnostic Tests in Oncology Market: Product Analysis

    • 5.1 Companion Diagnostic Tests in Oncology Product Market Share Analysis, 2018 & 2026

    • 5.2 Companion Diagnostic Tests in Oncology Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Companion Diagnostic Tests in Oncology Market: Application Analysis

    • 6.1 Companion Diagnostic Tests in Oncology Application Market Share Analysis, 2018 & 2026

    • 6.2 Companion Diagnostic Tests in Oncology Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Pharmaceutical & Biotechnology Companies

      • 6.3.2 Medical Device Companies

      • 6.3.3 Research Institutes

    7 Companion Diagnostic Tests in Oncology Market: Regional Analysis

    • 7.1 Companion Diagnostic Tests in Oncology Regional Market Share Analysis, 2018 & 2026

    • 7.2 Companion Diagnostic Tests in Oncology Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Company 1

      • 9.1.1 Company 1 Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Company 2

      • 9.2.1 Company 2 Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Company 3

      • 9.3.1 Company 3 Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Company 4

      • 9.4.1 Company 4 Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Company 5

      • 9.5.1 Company 5 Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Company 6

      • 9.6.1 Company 6 Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Company 7

      • 9.7.1 Company 7 Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Company 8

      • 9.8.1 Company 8 Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Company 9

      • 9.9.1 Company 9 Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Company 10

      • 9.10.1 Company 10 Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 87 Figures and 152 Tables)

    • Figure Protein Detection Companion Diagnostic Tests in Oncology market, 2015 - 2026 (USD Million)

    • Figure DNA Detection Companion Diagnostic Tests in Oncology market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical & Biotechnology Companies market, 2015 - 2026 (USD Million)

    • Figure Medical Device Companies market, 2015 - 2026 (USD Million)

    • Figure Research Institutes market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Companion Diagnostic Tests in Oncology market, by country, 2015 - 2026 (USD Million)

    • Table North America Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table North America Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table North America Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Canada Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Canada Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Europe Companion Diagnostic Tests in Oncology market, by country, 2015 - 2026 (USD Million)

    • Table Europe Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Europe Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Europe Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Germany Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Germany Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table France Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table France Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Italy Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Italy Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Spain Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Spain Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Companion Diagnostic Tests in Oncology market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table China Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table China Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Japan Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Japan Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table India Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table India Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Companion Diagnostic Tests in Oncology market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table MEA Companion Diagnostic Tests in Oncology market, by country, 2015 - 2026 (USD Million)

    • Table MEA Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table MEA Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table MEA Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Companion Diagnostic Tests in Oncology market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Companion Diagnostic Tests in Oncology market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Companion Diagnostic Tests in Oncology market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Company 1 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 2 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 3 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 4 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 5 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 6 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 7 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 8 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 9 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Company 10 Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US